Hematology Oncology Fellowship
Fellows in the Jefferson/Reading hematology-medical Oncology Track benefit from the strength of both institutions. At Reading Hospital and the McGlinn Cancer Institute, there is exposure to the wide range of hematologic and oncologic diseases seen in the primary care setting. Reading Hospital has more than 1,500 new cancer diagnoses per year as well as both benign and hematologic malignancy cases. There are 18 tumor boards each month and several multidisciplinary clinics in breast, lung and GI malignancy. There is an active clinical research program that enrolls more than 100 patients/year on clinical trials and registries. There are a mixture of socioeconomic and ethnic groups cared for at the hospital and clinic.
At Jefferson, there is the opportunity to train at an NCI designated Cancer Center with growing phase I program, hemopoietic stem-cell transplant program, leukemia/lymphoma service, well-developed multi-disciplinary teams and one of the finest general hematology training programs in the country. At Jefferson, rotations will include hematology consults, transfusion medicine, solid tumor oncology and work on the inpatient transplant and leukemia unit.
Jefferson is a 1,000 bed urban hospital in Philadelphia with an active environment for trainees. In the last few years, a rapid growth of clinical research programs at the Sidney Kimmel Cancer Center has attracted trainees who wish to pursue careers in academic and clinical medicine. There is a separate track for those interested in clinical careers. This track will provide more time at Reading Hospital with increased exposure to the wide range of cases commonly seen in a Community Cancer Center. Basic science and clinical conferences are shared by remote access between the two institutions.
It is the goal of the combined program that graduates obtain the professional, cognitive and technical skills to provide competent, compassionate care. Fellows will have the opportunity to practice patient communication and shared decision making and will learn to apply current evidence based knowledge relevant to patient care. Clinical training is achieved through a balance of self-directed learning, didactic sessions as well as mentoring. Fellows will have ample time and be encouraged to be involved in research projects at both institutions.
Nick Leasure, MD
Hematology/Oncology Site Director
Reading Health System